Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
about
Management of salivary gland carcinomas - a reviewPredictors of Nodal Metastasis in Parotid Malignancies: A National Cancer Data Base Study of 22,653 Patients.Review of clinical experience with ion beam radiotherapy.Nomograms for predicting long-term overall survival and cancer-specific survival in patients with major salivary gland cancer: a population-based study.The Value of F-18 FDG PET for Planning Treatment and Detecting Recurrence in Malignant Salivary Gland Tumors: Comparison with Conventional Imaging Studies.Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis.Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC.Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma.Survival outcome of malignant minor salivary tumors in Pakistani populationPrognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapyEpidemiological characteristics of head and neck cancers in southeast of iran.Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies.IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial.Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.The presence of facial nerve weakness on diagnosis of a parotid gland malignant process.Outcomes and prognostic factors in modern era management of major salivary gland cancer.Minor salivary gland tumours of upper aerodigestive tract: a clinicopathological study.Parotid carcinoma: Current diagnostic workup and treatment.Metastatic parotid myoepithelial carcinoma in a 7-year-old boy.What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck.Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft.Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?Salivary gland cancers: current treatments, molecular characteristics and new therapies.Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative studyValidation and Comparison of the 7th Edition of the American Joint Committee on Cancer Staging System and Other Prognostic Models to Predict Relapse-Free Survival in Asian Patients with Parotid Cancer.Feeding Tube Utilization in Patients with Salivary Gland Malignancies.Androgen Receptor Signaling in Salivary Gland Cancer.Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axisExpression of RECK and MMP-2 in salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis.Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology.Systemic therapy in the management of metastatic or advanced salivary gland cancers.Salivary gland carcinomas.Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma.Recent trends in the management of minor salivary gland carcinoma.Salivary mucoepidermoid carcinoma revisited.Salivary gland tumors in children: a retrospective clinical review.Unexpected Detection of Parotid Gland Malignancy during Primary Extracapsular Dissection.Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.Occult Temporal Bone Facial Nerve Involvement by Parotid Malignancies with Perineural Spread.
P2860
Q28069083-E17258E6-96E0-4384-8E6A-A366B81E085FQ30999260-A390B71C-AEE4-4DA2-A34C-717D0786AD3FQ33274099-A2563E2B-7908-43F3-A53A-6169DF666073Q33648534-B43ECF6E-BBDA-4962-AE6C-766AB8CE3ED8Q33669886-0F75145B-C43E-46D9-A13E-420F76D44874Q33710168-CD13654F-1666-4DC4-86D5-C54702663D3DQ33715048-8595B3D1-610B-40BE-AE7E-2C53B66B6AC7Q33913567-4EEF9A61-24C0-4AFC-B9E9-6B7943B2920DQ34052256-4DCC74BC-D331-4DDC-BCA4-D57F49DE74F1Q34056320-77A841C3-490D-43DB-9F5A-5B049881E6CFQ34082488-0E22427A-E239-46F9-B2DB-4694E73FB9DDQ34185900-64A56A2E-5D66-42A2-AABD-8B09B34D7887Q34253809-501DF849-D084-419E-B0E4-ACB3693FA89DQ35070144-65BEE126-98FC-4445-ABA0-6467433C8CCCQ35534813-65FF68C2-9B19-41B2-9F63-13E56D6823EDQ35851711-209EB4D0-3C4E-4630-A479-917AFE63AF5AQ35889915-47299DAC-497D-4750-9FCF-3467E0374D4AQ35999537-8AAB359A-46B7-4027-965B-8C4CBEA34D82Q36170033-12AC052D-C452-41DF-A7F3-F520C8EEC453Q36253567-2C11D5A0-DCA0-4D39-A738-E9B2CCBDF57CQ36345347-11D12C05-A147-4EA9-8C81-C154A9A3C863Q36920470-ADF75380-8EB8-4CF6-9BB5-1E54AE2D2FDEQ37073100-D0B46C98-8A6D-4C88-8484-922C97D9B3E7Q37134463-F5EED431-F539-4485-B57B-9D9E0FF8E17EQ37182834-D26B1EC7-A0E1-434D-94DE-0C8CD45105B5Q37290483-40250115-D69C-48A4-99F3-BCC01028763BQ37553089-2BDEAA26-74DB-4E6D-A2E6-5F678C7C5C6CQ37676074-36421BA3-83E4-4695-A326-AF497E18954DQ37687338-19E9B68C-4440-4EDD-B7C2-7E06BBAD58E0Q37719954-BEE8AC35-613E-48CF-AF60-67A4060AA8C3Q37880693-C6BA24CD-CD64-47A8-A991-50EE8399F195Q38007528-32A2CAE7-5B70-47E0-9214-FA821122FFE7Q38030395-3E456756-9387-4CDA-BAC7-5DC61AADA994Q38055702-C13FE208-CF74-49E6-84FF-0EC50BE9CDADQ38096338-5E4478B6-5D8E-4EF0-B4BF-8FBAAFB53E57Q38207529-8C640891-D06F-45B5-9C74-0FC66EAC7EE9Q38253385-D6E16D70-71DB-4999-95B5-FFDA2ADB6E5EQ38395230-D50EC2DE-0EF1-4B26-9EA8-F25CB14D7E6EQ38492040-E9A6F61B-4A97-44B1-B675-27ADFA0CBC10Q38541006-E4D98C49-BB3E-4CDF-A055-A63E07445B4B
P2860
Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Salivary gland carcinoma: inde ...... ck oncology cooperative group.
@en
Salivary gland carcinoma: inde ...... ck oncology cooperative group.
@nl
type
label
Salivary gland carcinoma: inde ...... ck oncology cooperative group.
@en
Salivary gland carcinoma: inde ...... ck oncology cooperative group.
@nl
prefLabel
Salivary gland carcinoma: inde ...... ck oncology cooperative group.
@en
Salivary gland carcinoma: inde ...... ck oncology cooperative group.
@nl
P2093
P2860
P356
P1433
P1476
Salivary gland carcinoma: inde ...... ck oncology cooperative group.
@en
P2093
Chris H J Terhaard
Dutch Head and Neck Oncology Cooperative Group
F J M Hilgers
H A M Marres
I Van der Tweel
J L N Roodenburg
J M A de Jong
R E Tjho-Heslinga
W M H Eijkenboom
P2860
P304
681-92; discussion 692-3
P356
10.1002/HED.10400
P577
2004-08-01T00:00:00Z